American Portfolios Advisors Citius Pharmaceuticals, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 4,000 shares of CTXR stock, worth $10,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000Holding current value
$10,960% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
7Shares Held
2.32MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$4.95 Million0.0% of portfolio
-
Chelsea Counsel CO281KShares$770,7620.07% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$422,3160.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ40.3KShares$110,3750.0% of portfolio
-
Ifp Advisors, Inc33.3KShares$91,3320.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $400M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...